Skip to main content
Công ty Cổ phần Dược phẩm Bến Tre logo

Công ty Cổ phần Dược phẩm Bến Tre — Investor Relations & Filings

Ticker · DBT ISIN · VN000000DBT6 HSX Manufacturing
Open in API
Filings indexed 414 across all filing types
Latest filing 2026-02-05 Transaction in Own Shar…
Country VN Viet Nam
Listing HSX DBT

About Công ty Cổ phần Dược phẩm Bến Tre

www.bepharco.com

Bepharco (Công ty Cổ phần Dược phẩm Bến Tre) is a pharmaceutical company established in 1963, with over 60 years of experience in the production and distribution of pharmaceutical products. The company specializes in a diverse range of offerings, including prescription drugs, health protection foods, and medical equipment. Key product areas include cardiovascular, digestive, and anti-allergy medications, as well as traditional medicine. Bepharco maintains an extensive distribution network across numerous provinces and cities, and exports its products globally. It is recognized for its commitment to quality and its strategic collaborations in pharmaceutical education and research.

Recent filings

Filing Released Lang Actions
DBT: Nghị quyết HĐQT về giao dịch bán cổ phiếu của Công ty Cổ phần Dược phẩm Trung ương Codupha
Transaction in Own Shares Classification · 87% confidence The document is an official disclosure to the State Securities Commission and Ho Chi Minh Stock Exchange of an extraordinary Board of Directors resolution approving the sale of shares held by Ben Tre Pharmaceutical JSC in Central Pharmaceutical (Codupha). It does not include full financial statements or statistical data but announces a share transaction (sale) by the company of its own shareholdings. This matches the definition of a Transaction in Own Shares (POS).
2026-02-05 Vietnamese
DBT: Báo cáo tình hình quản trị công ty năm 2025
Governance Information Classification · 95% confidence The document is titled “Report on Corporate Governance” and is addressed to the State Securities Commission and the Ho Chi Minh Stock Exchange. It details the company’s governance model, shareholder meeting activities and resolutions, board of directors’ composition and activities, audit committee and secretariat operations, and internal governance practices. It does not present full financial statements or act as a proxy solicitation or earnings release. Therefore, it aligns with the Governance Information category.
2026-01-30 Tagalog
DBT: Thông báo giao dịch cổ phiếu của người nội bộ Nguyễn Khắc Hanh
Director's Dealing Classification · 86% confidence The document is a Vietnamese/English bilingual notice to the State Securities Commission and stock exchange detailing an insider’s personal share transaction (name of individual, position, securities code, shares held, shares to sell, transaction period, etc.). This matches the definition of a Director’s Dealing report (insider trades).
2026-01-23 Vietnamese
DBT: Thông báo nhận được Công văn của VSDC về điều chỉnh loại chứng khoán
Regulatory Filings Classification · 85% confidence The document is a mandatory disclosure (‘Công Bố Thông Tin Bất Thường’) to the State Securities Commission and the stock exchange informing investors of a change in the type of securities (from restricted‐transfer to freely‐transferable) for 1,920,000 shares. It does not contain financial statements, earnings data, management commentary, or voting results—it is a regulatory announcement of a corporate action. There is no evidence of a share issuance, repurchase, dividend, or executive change. As it is a general regulatory filing for an extraordinary corporate disclosure not covered by a more specific category, it falls under Regulatory Filings (RNS).
2026-01-09 Vietnamese
DBT: Nghị quyết HĐQT về việc thông qua giao dịch liên quan
Regulatory Filings Classification · 82% confidence The document is a Vietnamese mandatory disclosure (“công bố thông tin bất thường”) notifying the securities regulator and stock exchange of a Board resolution approving related-party transactions. It is not a financial report, management discussion, dividend notice, or any specialized form; it is a standard corporate regulatory announcement. Therefore it falls into the fallback category “Regulatory Filings” (RNS).
2025-12-31 Vietnamese
DBT: Nghị quyết HĐQT về việc giao dịch bán cổ phiếu của Công ty Cổ phần Dược phẩm Trung ương Codupha
Transaction in Own Shares Classification · 78% confidence The document is an "unusual information" announcement (CBTT) and includes the board of directors’ resolution approving the sale of shares the company itself holds (3,470,000 shares of Codupha). This is a corporate action where the company disposes of its own shareholdings, corresponding to the “Transaction in Own Shares” category (POS).
2025-12-26 Vietnamese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.